Characteristics | CSA (n = 42) | DSA (n = 39) | Statistics | P value |
---|---|---|---|---|
Age | 57.9 ± 8.2 | 61.0 ± 8.9 | t = 1.386 | 0.171 |
Sex (male/female) | 26/16 | 30/9 | χ 2 = 2.138 | 0.158 |
BMI | 21.5 ± 3.5 | 22.8 ± 3.3 | t = −1.424 | 0.159 |
Diabetes | 2 (4.8) | 0 (0) | 0.494a | |
Hypertension | 5 (11.9) | 5 (12.8) | 1 a | |
Coronary artery disease | 2 (4.8) | 2 (5.1) | 1 a | |
Pathologic stage | ||||
I | 12 (28.6) | 13 (33.3) | 0.784 a | |
II | 16 (38.1) | 12 (30.8) | ||
III | 14 (33.3) | 13 (33.3) | ||
IV | 0 (0) | 1 (2.6) | ||
Location of tumour | ||||
Upper | 12 (28.6) | 6 (15.4) | 0.383 a | |
Middle | 24 (57.1) | 27 (69.2) | ||
Lower | 6 (14.3) | 6 (15.4) | ||
Surgical approach | ||||
MIE | 24 (57.1) | 28 (71.8) | χ 2 = 1.889 | 0.246 |
Open | 18 (42.9) | 11 (28.2) | ||
Neoadjuvant chemotherapy | 7 (16.7) | 5 (12.8) | χ 2 = 0.152 | 0.762 |